Advertisement

Topics

Lynzparza’s new tablet formulation gets FDA approval, expanded indication

11:59 EDT 18 Aug 2017 | Drug Store News

WILMINGTON, Del. — AstaZeneca and Merck’s Lynzparza (olaparib) tablets were approved by the Food and Drug Administration, as well as given an expanded indication by the regulatory agency.

read more

Original Article: Lynzparza’s new tablet formulation gets FDA approval, expanded indication

NEXT ARTICLE

More From BioPortfolio on "Lynzparza’s new tablet formulation gets FDA approval, expanded indication"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...